# Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0

> **NCT05965934** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sequana Medical N.V.** · enrollment: 33 (estimated)

## Conditions studied

- Heart Failure
- Volume Overload

## Interventions

- **DRUG:** Direct Sodium Removal Infusate 2.0

## Key facts

- **NCT ID:** NCT05965934
- **Lead sponsor:** Sequana Medical N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-07
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2023-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05965934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05965934, "Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05965934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*